Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Scott

Showing results (31-40 of 395) with videos related to

Pageof 40
Sort By:
Optics Letters|January 5, 2006
300 W quasi-continuous-wave diffraction-limited output from a diode-pumped Nd:YAG master oscillator power amplifier with fiber phase-conjugate stimulated Brillouin scattering mirrorValeri I Kovalev, Robert G Harrison, Andrew M Scott
Therapeutic Delivery|July 27, 2012
Monoclonal antibody dose determination and biodistribution into solid tumorsRobert A Beckman, Reinhard von Roemeling, Andrew M Scott
Nature Reviews. Cancer|March 23, 2012
Antibody therapy of cancerAndrew M Scott, Jedd D Wolchok, Lloyd J Old
Cancer Immunity|August 17, 2012
Monoclonal antibodies in cancer therapyAndrew M Scott, James P Allison, Jedd D Wolchok
Critical Reviews in Oncogenesis|April 5, 2012
Therapeutic targeting of the epidermal growth factor receptor in human cancerNathalie S Dhomen, John Mariadason, Niall Tebbutt, et al.
Expert Opinion on Investigational Drugs|May 23, 2025
Clinical development of tri-specific antibodies for immune-oncologyZhipeng Cao, Laura D Osellame, Laura Allan, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Antibody-drug conjugates: beyond current approvals and potential future strategiesSiddharth Menon, Sagun Parakh, Andrew M Scott, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 2, 2019
Current Development of Monoclonal Antibodies in Cancer TherapySagun Parakh, Dylan King, Hui K Gan, et al.
Molecular Cancer|September 29, 2022
Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibitionRoger J Daly, Andrew M Scott, Oliver Klein, et al.
Molecules (Basel, Switzerland)|October 21, 2020
Antibody-Drug Conjugates for Cancer TherapyUmbreen Hafeez, Sagun Parakh, Hui K Gan, et al.
Pageof 40

Showing results (31-40 of 395) with videos related to

Sort By:
Pageof 40
Optics Letters|January 5, 2006
300 W quasi-continuous-wave diffraction-limited output from a diode-pumped Nd:YAG master oscillator power amplifier with fiber phase-conjugate stimulated Brillouin scattering mirrorValeri I Kovalev, Robert G Harrison, Andrew M Scott
Therapeutic Delivery|July 27, 2012
Monoclonal antibody dose determination and biodistribution into solid tumorsRobert A Beckman, Reinhard von Roemeling, Andrew M Scott
Nature Reviews. Cancer|March 23, 2012
Antibody therapy of cancerAndrew M Scott, Jedd D Wolchok, Lloyd J Old
Cancer Immunity|August 17, 2012
Monoclonal antibodies in cancer therapyAndrew M Scott, James P Allison, Jedd D Wolchok
Critical Reviews in Oncogenesis|April 5, 2012
Therapeutic targeting of the epidermal growth factor receptor in human cancerNathalie S Dhomen, John Mariadason, Niall Tebbutt, et al.
Expert Opinion on Investigational Drugs|May 23, 2025
Clinical development of tri-specific antibodies for immune-oncologyZhipeng Cao, Laura D Osellame, Laura Allan, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Antibody-drug conjugates: beyond current approvals and potential future strategiesSiddharth Menon, Sagun Parakh, Andrew M Scott, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 2, 2019
Current Development of Monoclonal Antibodies in Cancer TherapySagun Parakh, Dylan King, Hui K Gan, et al.
Molecular Cancer|September 29, 2022
Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibitionRoger J Daly, Andrew M Scott, Oliver Klein, et al.
Molecules (Basel, Switzerland)|October 21, 2020
Antibody-Drug Conjugates for Cancer TherapyUmbreen Hafeez, Sagun Parakh, Hui K Gan, et al.
Pageof 40